Thermal ablation of pancreatic cancer: A systematic literature review of clinical practice and pre-clinical studies

References

• Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–1046.
   PubMed Web of Science ®Google Scholar
• Kommalapati A, Tella SH, Goyal G, et al. Contemporary management of localized resectable pancreatic cancer. Cancers (Basel). 2018;10(1):1–15.
   Google Scholar
• American Cancer Society. Cancer facts and figures 2013. Atlanta: American Cancer Society; 2013.
   Google Scholar
• Sheahan AV, Biankin AV, Parish CR, et al. Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review. Oncotarget. 2018;9:21613–21627.
   PubMedGoogle Scholar
• International Agency for Research on Cancer (IARC). http://www.iarc.fr/.
   Google Scholar
• Chin V, Nagrial A, Sjoquist K, et al. Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database Syst Rev. 2018;3:CD011044.
   PubMed Web of Science ®Google Scholar
• Gillen S, Schuster T, Meyer Zum Buschenfelde C, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7:e1000267.
   PubMed Web of Science ®Google Scholar
• Hammel P, Huguet F, van Laethem JL, et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA. 2016;315:1844–1853.
   PubMed Web of Science ®Google Scholar
• Marien A, Gill I, Ukimura O, et al. Target ablation—Image-guided therapy in prostate cancer. Urol Oncol; 2014:32(6):912–923.
   Google Scholar
• Petre EN, Sofocleous C. Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease. Visc Med. 2017;33:62–68.
   PubMed Web of Science ®Google Scholar
• O'Neal D, Cohen T, Peterson C, et al. Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors. 2018;5:7–14.
   Google Scholar
• Welch AJ, Van Gemert MJ. Optical-thermal response of laser-irradiated tissue. Vol. 2. Dordrecht: Springer; 2011.
   Google Scholar
• Schena E, Saccomandi P, Fong Y. Laser ablation for cancer: past, present and future. J Funct Biomater. 2017;8:19.
   PubMed Web of Science ®Google Scholar
• Saccomandi P, Schena E, Diana M, et al. Thermal treatments of tumors: principles and methods. In: Piemonte V, Basile A, Ito T, Marrelli L, editors. Biomedical engineering challenges: a chemical engineering insight. Chapter 10. 1st ed. Wiley; 2018. p. 199–228.
   Google Scholar
• Menovsky T, Beek J, Van Gemert M, et al. Interstitial laser thermotherapy in neurosurgery: a review. Acta Neurochir (Wien). 1996;138:1019–1026.
   PubMed Web of Science ®Google Scholar
• Di Matteo F, Picconi F, Martino M, et al. Endoscopic ultrasound-guided Nd:YAG laser ablation of recurrent pancreatic neuroendocrine tumor: a promising revolution? Endoscopy. 2014;46: (Suppl 1 UCTN):E380–E381.
   PubMed Web of Science ®Google Scholar
• Mooney R, Schena E, Saccomandi P, et al. Gold nanorod-mediated near-infrared laser ablation: in vivo experiments on mice and theoretical analysis at different settings. Int J Hyperther. 2017;33:150–159.
   PubMed Web of Science ®Google Scholar
• Mocan L, Tabaran FA, Mocan T, et al. Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubes. Int J Nanomed. 2011;6:915–928.
   PubMed Web of Science ®Google Scholar
• Allegretti G, Saccomandi P, Giurazza F, et al. Magnetic resonance-based thermometry during laser ablation on ex-vivo swine pancreas and liver. Med Eng Phys. 2015;37:631–641.
   PubMed Web of Science ®Google Scholar
• Di Matteo F, Martino M, Rea R, et al. US-guided application of Nd:YAG laser in porcine pancreatic tissue: an ex vivo study and numerical simulation. Gastrointest Endosc. 2013; 78:750–755. doi: 10.1016/j.gie.2013.04.178.
   PubMed Web of Science ®Google Scholar
• Di Matteo F, Martino M, Rea R, et al. EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. Gastrointest Endosc. 2010;72:358–363.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang Z, Kim DH, et al. Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int J Nanomed. 2013;8:3437–3446.
   PubMed Web of Science ®Google Scholar
• Mocan T, Matea CT, Cojocaru I, et al. Photothermal treatment of human pancreatic cancer using PEGylated multi-walled carbon nanotubes induces apoptosis by triggering mitochondrial membrane depolarization mechanism. J Cancer. 2014;5:679.
   PubMed Web of Science ®Google Scholar
• Saccomandi P, Schena E, Caponero MA, et al. Theoretical analysis and experimental evaluation of laser-induced interstitial thermotherapy in ex vivo porcine pancreas. IEEE Trans Biomed Eng. 2012;59:2958–2964.
   PubMed Web of Science ®Google Scholar
• Saccomandi P, Schena E, Di Matteo FM, et al. Theoretical assessment of principal factors influencing laser interstitial thermotherapy outcomes on pancreas. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5687–5690.
   PubMedGoogle Scholar
• Saccomandi P, Schena E, Di Matteo FM, et al. Laser interstitial thermotherapy for pancreatic tumor ablation: theoretical model and experimental validation. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5585–5588.
   PubMedGoogle Scholar
• Schena E, Majocchi L. Assessment of temperature measurement error and its correction during Nd: YAG laser ablation in porcine pancreas. Int J Hyperthermia. 2014;30:328–334.
   PubMed Web of Science ®Google Scholar
• Schena E, Saccomandi P, Giurazza F, et al. Experimental assessment of CT-based thermometry during laser ablation of porcine pancreas. Phys Med Biol. 2013;58:5705–5716.
   PubMed Web of Science ®Google Scholar
• Stroszczynski C, Hosten N, Puls R, et al. Histopathological correlation to MRI findings during and after laser-induced thermotherapy in a pig pancreas model. Invest Radiol. 2001;36:413–421.
   PubMed Web of Science ®Google Scholar
• Bruners P, Levit E, Penzkofer T, et al. Multi-slice computed tomography: A tool for non-invasive temperature measurement? Int J Hyperthermia. 2010;26:359–365.
   PubMed Web of Science ®Google Scholar
• Di Matteo FM, Saccomandi P, Martino M, et al. Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointest Endosc. 2018;88(1):168–174.e1.
   PubMed Web of Science ®Google Scholar
• Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound. 2001;13:129–147.
   PubMedGoogle Scholar
• Pereira PL, Trubenbach J, Schenk M, et al. Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology. 2004;232:482–490.
   PubMed Web of Science ®Google Scholar
• Fegrachi S, Besselink MG, van Santvoort HC, et al. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford). 2014;16:119–123.
   PubMed Web of Science ®Google Scholar
• Date RS, McMahon RF, Siriwardena AK. Radiofrequency ablation of the pancreas. I: Definition of optimal thermal kinetic parameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP. 2005;6:581–587.
   PubMedGoogle Scholar
• Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50:392–401
   PubMed Web of Science ®Google Scholar
• Date RS, Biggins J, Paterson I, et al. Development and validation of an experimental model for the assessment of radiofrequency ablation of pancreatic parenchyma. Pancreas. 2005;30:266–271.
   PubMed Web of Science ®Google Scholar
• Gaidhane M, Smith I, Ellen K, et al. Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of the Pancreas in a Porcine Model. Gastroenterol Res Pract. 2012;2012:1.
   Web of Science ®Google Scholar
• Kim HJ, Seo DW, Hassanuddin A, et al. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc. 2012;76:1039–1043.
   PubMed Web of Science ®Google Scholar
• Fegrachi S, Molenaar IQ, Klaessens JH, et al. Radiofrequency ablation of the pancreas: two-week follow-up in a porcine model. Eur J Surg Oncol. 2014;40:1000–1007.
   PubMed Web of Science ®Google Scholar
• Quesada R, Burdío F, Iglesias M, et al. Radiofrequency pancreatic ablation and section of the main pancreatic duct does not lead to necrotizing pancreatitis. Pancreas. 2014;43:931–937.
   PubMed Web of Science ®Google Scholar
• Raoof M, Cisneros BT, Corr SJ, et al. Tumor selective hyperthermia induced by short-wave capacitively-coupled RF electric-fields. PLoS One. 2013;8:e68506.
   PubMed Web of Science ®Google Scholar
• D'Onofrio M, Barbi E, Girelli R, et al. Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma. J Gastrointest Oncol. 2016;7:213–220.
   PubMed Web of Science ®Google Scholar
• D’Onofrio M, Crosara S, De Robertis R, et al. Percutaneous radiofrequency ablation of unresectable locally advanced pancreatic cancer: preliminary results. Technol Cancer Res Treat. 2017;16:285–294.
   PubMed Web of Science ®Google Scholar
• Giardino A, Girelli R, Frigerio I, et al. Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB (Oxford). 2013;15:623–627.
   PubMed Web of Science ®Google Scholar
• Hadjicostas P, Malakounides N, Varianos C, et al. Radiofrequency ablation in pancreatic cancer. HPB (Oxford). 2006;8:61–64.
   PubMedGoogle Scholar
• Ikuta S, Kurimoto A, Iida H, et al. Optimal combination of radiofrequency ablation with chemoradiotherapy for locally advanced pancreatic cancer. World J Clin Oncol. 2012;3:12–14.
   PubMedGoogle Scholar
• Kallis Y, Phillips N, Steel A, et al. Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci. 2015;60:3449–3455.
   PubMed Web of Science ®Google Scholar
• Lakhtakia S, Ramchandani M, Galasso D, et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc. 2016;83:234–239.
   PubMed Web of Science ®Google Scholar
• Pai M, Habib N, Senturk H, et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015;7:52–59.
   PubMed Web of Science ®Google Scholar
• Rossi S, Viera FT, Ghittoni G, et al. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas. 2014;43:938–945.
   PubMed Web of Science ®Google Scholar
• Song TJ, Seo DW, Lakhtakia S, et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83:440–443.
   PubMed Web of Science ®Google Scholar
• Spiliotis JD, Datsis AC, Michalopoulos NV, et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg. 2007;392:55–60.
   PubMed Web of Science ®Google Scholar
• Varshney S, Sewkani A, Sharma S, et al. Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP. 2006;7:74–78.
   PubMedGoogle Scholar
• Waung JA, Todd JF, Keane MG, et al. Successful management of a sporadic pancreatic insulinoma by endoscopic ultrasound-guided radiofrequency ablation. Endoscopy. 2016;48:E144–E145.
   PubMed Web of Science ®Google Scholar
• Zou YP, Li WM, Zheng F, et al. Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer. World J Gastroenterol. 2010;16:5104–5110.
   PubMed Web of Science ®Google Scholar
• Rossmann C, Haemmerich D. Review of temperature dependence of thermal properties, dielectric properties, and perfusion of biological tissues at hyperthermic and ablation temperatures. Crit Rev Biomed Eng. 2014;42:467.
   PubMedGoogle Scholar
• Dodd GD, Dodd NA, Lanctot AC, et al. Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology. 2013;267:129–136.
   PubMed Web of Science ®Google Scholar
• Wright AS, Sampson LA, Warner TF, et al. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236:132–139.
   PubMed Web of Science ®Google Scholar
• Yang D, Bertram JM, Converse MC, et al. A floating sleeve antenna yields localized hepatic microwave ablation. IEEE Trans Biomed Eng. 2006;53:533–537.
   PubMed Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3:317–325.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Int J Hyperthermia. 2016;32:339–344.
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Ierardi AM, Fontana F, et al. Microwave ablation of pancreatic head cancer: safety and efficacy. J Vasc Interv Radiol. 2013;24:1513–1520.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247.
   PubMed Web of Science ®Google Scholar
• Al-Bataineh O, Jenne J, Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat Rev. 2012;38:346–353.
   PubMed Web of Science ®Google Scholar
• Crouzet S, Murat FJ, Pasticier G, et al. High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives. Int J Hyperthermia. 2010;26:796–803.
   PubMed Web of Science ®Google Scholar
• Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93:890–895.
   PubMed Web of Science ®Google Scholar
• Mo S, Coussios C-C, Seymour L, et al. Ultrasound-enhanced drug delivery for cancer. Expert Opin Drug Deliv. 2012;9:1525–1538.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Wang YN, Warren C, et al. Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol. 2009;35:967–975.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim H, Kim YJ, et al. Dynamic contrast–enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse xenograft model of human pancreatic cancer. Eur Radiol. 2014;24:2059–2068.
   PubMed Web of Science ®Google Scholar
• Lee ES, Lee JY, Kim H, et al. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine. Ultrasound Med Biol. 2013;39:1991–2000.
   PubMed Web of Science ®Google Scholar
• Li T, Chen H, Khokhlova T, et al. Passive cavitation detection during pulsed HIFU exposures of ex vivo tissues and in vivo mouse pancreatic tumors. Ultrasound Med Biol. 2014;40:1523–1534.
   PubMed Web of Science ®Google Scholar
• Li T, Khokhlova T, Maloney E, et al. Endoscopic high-intensity focused US: technical aspects and studies in an in vivo porcine model (with video). Gastrointestinal Endoscopy. 2015;81:1243–1250.
   PubMed Web of Science ®Google Scholar
• Xie B, Li YY, Jia L, et al. Experimental ablation of the pancreas with high intensity focused ultrasound (HIFU) in a porcine model. Int J Med Sci. 2010;8:9–15.
   PubMed Web of Science ®Google Scholar
• Anzidei M, Napoli A, Sandolo F, et al. Magnetic resonance-guided focused ultrasound ablation in abdominal moving organs: a feasibility study in selected cases of pancreatic and liver cancer. Cardiovasc Intervent Radiol. 2014;37:1611–1617.
   PubMed Web of Science ®Google Scholar
• Ge H-Y, Miao L-Y, Xiong L-L, et al. High-intensity focused ultrasound treatment of late-stage pancreatic body carcinoma: optimal tumor depth for safe ablation. Ultrasound Med Biol. 2014;40:947–955.
   PubMed Web of Science ®Google Scholar
• Jung SE, Cho SH, Jang JH, et al. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom Imaging. 2011;36:185–195.
   PubMedGoogle Scholar
• Lee JY, Choi BI, Ryu JK, et al. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Korean J Radiol. 2011;12:176–186.
   PubMed Web of Science ®Google Scholar
• Li P-Z, Zhu S-H, He W, et al. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer. Hepatobiliary Pancreatic Dis Int. 2012;11:655–660.
   PubMed Web of Science ®Google Scholar
• Li Y-J, Huang G-L, Sun X-L, et al. The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma. World J Surg Onc. 2016;14:60.
   PubMed Web of Science ®Google Scholar
• Marinova M, Rauch M, Mücke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26:4047–4056.
   PubMed Web of Science ®Google Scholar
• Orgera G, Monfardini L, Della Vigna P, et al. High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results. Radiol Med. 2011;116:734–748.
   PubMed Web of Science ®Google Scholar
• Orsi F, Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. Amer J Roentgenol. 2010;195:W245–W252.
   PubMed Web of Science ®Google Scholar
• Strunk H, Henseler J, Rauch M, et al. editors. Clinical use of High-Intensity Focused Ultrasound (HIFU) for tumor and pain reduction in advanced pancreatic cancer. RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren; 2016. Rofo. 2016;188(7):662–670.
   Google Scholar
• Sung HY, Jung SE, Cho SH, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas. 2011;40:1080–1086.
   PubMed Web of Science ®Google Scholar
• Vidal-Jove J, Perich E, del Castillo MA. Ultrasound guided high intensity focused ultrasound for malignant tumors: the Spanish experience of survival advantage in stage III and IV pancreatic cancer. Ultrasonics Sonochem. 2015;27:703–706.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhou D. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases. Ultrasonics Sonochem. 2015;27:694–702.
   PubMed Web of Science ®Google Scholar
• Wang K, Chen Z, Meng Z, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperther. 2011;27:101–107.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhu H, Meng Z, et al. Safety evaluation of high-intensity focused ultrasound in patients with pancreatic cancer. Oncology Research and Treatment. Onkologie. 2013;36:88–92.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang Z-B, Zhu H, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology. 2005;236:1034–1040.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yang G, Wang D, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anti-Cancer Drugs. 2010;21:447–452.
   PubMed Web of Science ®Google Scholar
• Sofuni A, Moriyasu F, Sano T, et al. The current potential of high‐intensity focused ultrasound for pancreatic carcinoma. J Hepato-Biliary-Pancreatic Sci. 2011;18:295–303.
   PubMed Web of Science ®Google Scholar
• Tatli S, Acar M, Tuncali K, et al. Percutaneous cryoablation techniques and clinical applications. Diagn Interv Radiol. 2010;16:90–95.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
   PubMed Web of Science ®Google Scholar
• Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21:S187–S191.
   PubMed Web of Science ®Google Scholar
• Lovelock JE. The haemolysis of human red blood-cells by freezing and thawing. Biochim Biophys Acta. 1953;10:414–426.
   PubMed Web of Science ®Google Scholar
• Luo XM, Niu LZ, Chen JB, et al. Advances in cryoablation for pancreatic cancer. World J Gastroenterol. 2016;22:790–800.
   PubMed Web of Science ®Google Scholar
• Korpan NN. Cryosurgery: ultrastructural changes in pancreas tissue after low temperature exposure. Technol Cancer Res Treat. 2007;6:59–67.
   PubMed Web of Science ®Google Scholar
• Niu L, Chen J, He L, et al. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Pancreas. 2013;42:1143–1149.
   PubMed Web of Science ®Google Scholar
• Carrara S, Arcidiacono P, Albarello L, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40:321–326.
   PubMed Web of Science ®Google Scholar
• Petrone MC, Arcidiacono PG, Carrara S, et al. US-guided application of a new hybrid probe in human pancreatic adenocarcinoma: an ex vivo study. Gastrointest Endosc. 2010;71:1294–1297.
   PubMed Web of Science ®Google Scholar
• Adams MS, Salgaonkar VA, Plata, ‐et al. Endoluminal ultrasound applicators for MR‐guided thermal ablation of pancreatic tumors: Preliminary design and evaluation in a porcine pancreas model. Med Phys. 2016;43:4184–4197.
   PubMed Web of Science ®Google Scholar
• Arcidiacono PG, Carrara S, Reni M, et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76:1142–1151.
   PubMed Web of Science ®Google Scholar
• Zuckerman DS, Ryan DP. Adjuvant therapy for pancreatic cancer: a review. Cancer. 2008;112:243–249.
   PubMed Web of Science ®Google Scholar
• Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–1825.
   PubMed Web of Science ®Google Scholar
• Xinopoulos D, Dimitroulopoulos D, Karanikas I, et al. Gemcitabine as palliative treatment in patients with unresectable pancreatic cancer previously treated with placement of a covered metal stent. A randomized controlled trial. J Buon. 2008;13:341–347.
   PubMed Web of Science ®Google Scholar
• Huguet F, Andre T, Hammel P, et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol. 2007;25:326–331.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Rana V, Janjan NA, et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer. 2007;110:47–55.
   PubMed Web of Science ®Google Scholar
• Grainne M, Knox JJ. Locally advanced pancreatic cancer: an emerging entity. Curr Probl Cancer. 2018;42(1):12–25.
   PubMed Web of Science ®Google Scholar
• Ng SP, Herman JM. Stereotactic radiotherapy and particle therapy for pancreatic cancer. Cancers (Basel). 2018;10:75.
   PubMed Web of Science ®Google Scholar
• Hirsch LR, Stafford RJ, Bankson J, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Nat Acad Sci. 2003;100:13549–13554.
   PubMed Web of Science ®Google Scholar
• Stern JM, Kibanov Solomonov VV, Sazykina E, et al. Initial evaluation of the safety of nanoshell-directed photothermal therapy in the treatment of prostate disease. Int J Toxicol. 2016;35:38–46.
   PubMed Web of Science ®Google Scholar
• Sonalleve MR-HIFU System. http://www.profoundmedical.com/sonalleve/.
   Google Scholar
• Sonacare Medical HIFU system. https://sonacaremedical.com/
   Google Scholar
• Khokhlova TD, Hwang JH. HIFU for palliative treatment of pancreatic cancer. J Gastrointest Oncol. 2011;2:175–184.
   PubMedGoogle Scholar
• She WH, Cheung TT, Jenkins CR, et al. Clinical applications of high-intensity focused ultrasound. Hong Kong Med J. 2016;22:382–392.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhou K, Zhang L, et al. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection. Eur J Radiol. 2009;72:160–166.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu H, Jin C, et al. High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol. 2009;19:437–445.
   PubMed Web of Science ®Google Scholar
• Marrocchio C, Dababou S, Catalano C, et al. Nonoperative Ablation of Pancreatic Neoplasms. Surg Clin North Am. 2018;98:127–140.
   PubMed Web of Science ®Google Scholar
• D’Onofrio M, Ciaravino V, De Robertis R, et al. Percutaneous ablation of pancreatic cancer. World J Gastroenterol. 2016; 22:9661–9673.
   PubMed Web of Science ®Google Scholar
• Iida H, Aihara T, Ikuta S, et al. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping. World J Gastroenterol. 2012;18:5870–5878.
   PubMed Web of Science ®Google Scholar